Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Revance Therapeutics (NQ: RVNC ) 6.580 +0.010 (+0.15%) Streaming Delayed Price Updated: 4:00 PM EDT, Sep 6, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Revance Therapeutics < Previous 1 2 ... 7 8 9 10 11 12 13 14 Next > Investor Action Alert: The Schall Law Firm Encourages Investors in Revance Therapeutics, Inc. with Losses of $100,000 to Contact the Firm December 21, 2021 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire Topics Lawsuit Exposures Financial Legal Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Revance Therapeutics, Inc. (RVNC) December 21, 2021 From Glancy Prongay & Murray LLP Via Business Wire SmileDirect Club Stock Isn’t Making a Comeback Any Time in the Near Future December 21, 2021 SmileDirect sells itself as a growth stock, selling orthodontic services directly through storefronts. But without growth, few are buying. Via InvestorPlace RVNC Shareholders: Robbins LLP Reminds Investors of Class Action Against Revance Therapeutics, Inc. (RVNC) December 21, 2021 From Robbins LLP Via Business Wire Revance Therapeutics Class Action Reminder December 16, 2021 Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Revance Therapeutics To Contact Him Directly To Discuss Their Options Via NewMediaWire Revance Therapeutics Deadline Alert December 20, 2021 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire Shareholder Action Reminder: The Schall Law Firm Encourages Investors in Revance Therapeutics, Inc. with Losses of $100,000 to Contact the Firm December 20, 2021 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire Topics Lawsuit Exposures Financial Legal RVNC Investor Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Revance Therapeutics, Inc. Investors of Class Action and Encourages Shareholders to Contact the Firm December 20, 2021 From Bronstein, Gewirtz & Grossman, LLC Via Business Wire Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Revance Therapeutics, Inc. (RVNC) December 20, 2021 From Law Offices of Howard G. Smith Via Business Wire REVANCE THERAPEUTICS SHAREHOLDER ALERT December 14, 2021 Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Revance Therapeutics To Contact Him Directly To Discuss Their Options Via NewMediaWire REVANCE THERAPEUTICS DEADLINE ALERT December 13, 2021 Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Revance Therapeutics To Contact Him Directly To Discuss Their Options Via NewMediaWire Kessler Topaz Meltzer & Check, LLP: Reminds Investors of Securities Fraud Class Action Filed Against Revance Therapeutics, Inc. December 17, 2021 From Kessler Topaz Meltzer & Check, LLP Via Business Wire Reminder: The Schall Law Firm Encourages Investors in Revance Therapeutics, Inc. with Losses of $100,000 to Contact the Firm December 17, 2021 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire Topics Lawsuit Exposures Financial Legal Investor Reminder: The Schall Law Firm Encourages Investors in Revance Therapeutics, Inc. with Losses of $100,000 to Contact the Firm December 17, 2021 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire Topics Lawsuit Exposures Financial Legal ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Revance Therapeutics, Inc. Investors to Secure Counsel Before Important February 8 Deadline in Securities Class Action – RVNC December 17, 2021 From The Rosen Law Firm, P.A. Via Business Wire INVESTOR ACTION NOTICE: The Schall Law Firm Encourages Investors in Revance Therapeutics, Inc. with Losses of $100,000 to Contact the Firm December 16, 2021 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire Topics Lawsuit Exposures Financial Legal Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a Securities Class Action on Behalf of Revance Therapeutics, Inc. (RVNC) Investors December 16, 2021 From Glancy Prongay & Murray LLP Via Business Wire INVESTOR ACTION ALERT: The Schall Law Firm Encourages Investors in Revance Therapeutics, Inc. with Losses of $100,000 to Contact the Firm December 15, 2021 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire Topics Lawsuit Exposures Financial Legal INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Revance Therapeutics, Inc. (RVNC) Investors December 15, 2021 From Law Offices of Howard G. Smith Via Business Wire RVNC SHAREHOLDERS: Robbins LLP Informs Investors of Class Action Against Revance Therapeutics, Inc. (RVNC) December 15, 2021 From Robbins LLP Via Business Wire The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Revance Therapeutics, Inc. (RVNC) Investors December 15, 2021 From The Law Offices of Frank R. Cruz Via Business Wire Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Revance Therapeutics, Inc. (RVNC) on Behalf of Investors December 14, 2021 From Glancy Prongay & Murray LLP Via Business Wire SHAREHOLDER ACTION REMINDER: The Schall Law Firm Encourages Investors in Revance Therapeutics, Inc. with Losses of $100,000 to Contact the Firm December 14, 2021 From The Schall Law Firm Via Business Wire 12 Health Care Stocks Moving In Tuesday's Pre-Market Session December 14, 2021 Gainers Galera Therapeutics (NASDAQ:GRTX) stock increased by 134.05% to $3.23 during Tuesday's pre-market session. The market value of their outstanding shares is at $... Via Benzinga REVANCE ALERT: Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against Revance Therapeutics, Inc. and Encourages Investors to Contact the Firm December 13, 2021 From Bragar Eagel & Squire, P.C. Via Business Wire ALERT: Revance Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - RVNC December 13, 2021 From Robbins Geller Rudman & Dowd LLP Via Business Wire The Law Offices of Frank R. Cruz Announces Investigation of Revance Therapeutics, Inc. (RVNC) on Behalf of Investors December 13, 2021 From Law Offices of Frank R. Cruz Via Business Wire SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Revance Therapeutics, Inc. with Losses of $100,000 to Contact the Firm December 13, 2021 From The Schall Law Firm Via Business Wire INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Revance Therapeutics, Inc. (RVNC) on Behalf of Investors December 13, 2021 From Law Offices of Howard G. Smith Via Business Wire EQUITY ALERT: ROSEN, A TOP RANKED LAW FIRM, Encourages Revance Therapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – RVNC December 13, 2021 From The Rosen Law Firm, P.A. Via Business Wire < Previous 1 2 ... 7 8 9 10 11 12 13 14 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.